SEARCH

SEARCH BY CITATION

References

  • 1
    Hastan D, Fokkens WJ, Bachert C, Newson RB, Bislimovska J, Bockelbrink A et al. Chronic rhinosinusitis in Europe an 4 underestimated disease. A GA(2)LEN study. Allergy 2011;66:12161223.
  • 2
    Tomassen P, Newson RB, Hoffmans R, Lotvall J, Cardell LO, Gunnbjornsdottir M et al. Reliability of EP3OS symptom criteria and nasal endoscopy in the assessment of chronic rhinosinusitis a GA(2)LEN study. Allergy 2011;66:556561.
  • 3
    Jarvis D, Newson R, Lotvall J, Hastan D, Tomassen P, Gjomarkaj M et al. Asthma in adults and its association with chronic rhinosinusitis: the GA2LEN survey in Europe. Allergy 2012;67:9198.
  • 4
    Bachert C, Gevaert P, Holtappels G, Johansson SG, Van Cauwenberge P. Total and specific IgE in nasal polyps is related to local eosinophilic inflammation. J Allergy Clin Immunol 2001;107:607614.
  • 5
    Bachert C, Gevaert P, Van Cauwenberge P. Staphylococcus aureus enterotoxins: a key in airway disease? Allergy 2002;57:480487.
  • 6
    Videler WJ, Badia L, Harvey RJ, Gane S, Georgalas C, van der Meulen FW et al. Lack of efficacy of long-term, low-dose 15 azithromycin in chronic rhinosinusitis: a randomized controlled trial. Allergy 2011;66:14571468.
  • 7
    Wymann MP, Schneiter R. Lipid signalling in disease. Nat Rev Mol Cell Biol 2008;9:162176.
  • 8
    Funk CD. Prostaglandins and leukotrienes: advances in eicosanoid biology. Science 2001;294:18711875.
  • 9
    Toda A, Yokomizo T, Shimizu T. Leukotriene B4 receptors. Prostaglandins Other Lipid Mediat 2002;69:575585.
  • 10
    Dahlen SE, Hedqvist P, Hammarstrom S, Samuelsson B. Leukotrienes are potent constrictors of human bronchi. Nature 1980;288:484486.
  • 11
    Brady HR, Papayianni A, Serhan CN. Potential vascular roles for lipoxins in the “stop programs” of host defense and inflammation. Trends Cardiovasc Med 1995;5:186192.
  • 12
    Serhan CN, Sheppard KA. Lipoxin formation during human neutrophil-platelet interactions. Evidence for the transformation of leukotriene A4 by platelet 12-lipoxygenase in vitro. J Clin Invest 1990;85:772780.
  • 13
    Serhan CN, Levy BD, Clish CB, Gronert K, Chiang N. Lipoxins, aspirin-triggered 15-epi-lipoxin stable analogs and their receptors in anti-inflammation: a window for therapeutic opportunity. Ernst Schering Res Found Workshop 2000;31:143185.
  • 14
    Bandeira-Melo C, Weller PF. Eosinophils and cysteinyl leukotrienes. Prostaglandins Leukot Essent Fatty Acids 2003;69:135143.
  • 15
    Accomazzo MR, Rovati GE, Vigano T, Hernandez A, Bonazzi A, Bolla M et al. Leukotriene D4-induced activation of smooth-muscle cells from human bronchi is partly Ca2+-independent. Am J Respir CritCare Med 2001;163:266272.
  • 16
    Pinto S, Gallo O, Polli G, Boccuzzi S, Paniccia R, Brunelli T et al. Cyclooxygenase and lipoxygenase metabolite generation in nasal polyps. Prostaglandins Leukot Essent Fatty Acids 1997;57:533537.
  • 17
    Pérez-Novo CA, Watelet JB, Claeys C, Van Cauwenberge P, Bachert C. Prostaglandin, 1 leukotriene, and lipoxin balance in chronic rhinosinusitis with and without nasal polyposis. J Allergy Clin Immunol 2005;115:11891196.
  • 18
    Pérez-Novo CA, Claeys C, Van Zele T, Holtapples G, Van Cauwenberge P, Bachert C. Eicosanoid metabolism and eosinophilic inflammation in nasal polyp patients with immune response to Staphylococcus aureus enterotoxins. Am J Rhinol 2006;20:456460.
  • 19
    Sousa AR, Parikh A, Scadding G, Corrigan CJ, Lee TH. Leukotriene-receptor expression on nasal mucosal inflammatory cells in aspirin-sensitive rhinosinusitis. N Engl J Med 2002;347:14931499.
  • 20
    Roca-Ferrer J, Garcia-Garcia FJ, Pereda J, Perez-Gonzalez M, Pujols L, Alobid I et al. Reduced expression of COXs and production of prostaglandin E(2) in patients with nasal polyps with or without aspirin intolerant asthma. J Allergy Clin Immunol 2011;128:6672.
  • 21
    Pérez-Novo CA, Claeys C, Van Cauwenberge P, Bachert C. Expression of eicosanoid receptors subtypes and eosinophilic inflammation: implication on chronic rhinosinusitis. Respir Res 2006;7:75.
  • 22
    Mita H, Hasegawa M, Higashi N, Akiyama K. Characterization of PGE2 receptor subtypes in human eosinophils. J Allergy Clin Immunol 2002;110:457459.
  • 23
    Tenor H, Hatzelmann A, Church MK, Schudt C, Shute JK. Effects of theophylline and rolipram on leukotriene C4 (LTC4) synthesis and chemotaxis of human eosinophils from normal and atopic subjects. Br J Pharmacol 1996;118:17271735.
  • 24
    Peacock CD, Misso NL, Watkins DN, Thompson PJ. PGE2 and dibutyryl cyclic adenosine monophosphate prolong eosinophil survival in vitro. J Allergy Clin Immunol 1999;104:153162.
  • 25
    Liu CM, Hong CY, Shun CT, Hsiao TY, Wang CC, Wang JS et al. Inducible cyclooxygenase 1 and interleukin 6 gene expressions in nasal polyp fibroblasts: possible implication in the pathogenesis of nasal polyposis. Arch Otolaryngol Head Neck Surg 2002;128:945951.
  • 26
    Cho KN, Choi JY, Kim CH, Baek SJ, Chung KC, Moon UY et al. Prostaglandin E2 induces MUC8 gene expression via a mechanism involving ERK MAPK/RSK1/cAMP response element binding protein activation in human airway epithelial cells. J Biol Chem 2005;280:66766681.
  • 27
    Van Bruaene N, Derycke L, Pérez-Novo CA, Gevaert P, Holtappels G, De Ruyck N et al. TGF-beta signaling and collagen deposition in chronic rhinosinusitis. J Allergy Clin Immunol 2009;124:253259.
  • 28
    Patou J, Holtappels G, Affleck K, Gevaert P, Pérez-Novo C, Van Cauwenberge P et al. Enhanced release of IgE-dependent early phase mediators from nasal polyp tissue. J Inflamm (Lond) 2009;6:11.
  • 29
    Okano M, Fujiwara T, Yamamoto M, Sugata Y, Matsumoto R, Fukushima K et al. Role of prostaglandin D2 and E2 terminal synthases in chronic rhinosinusitis. Clin Exp Allergy 2006;36:10281038.
  • 30
    Yamamoto M, Okano M, Fujiwara T, Kariya S, Higaki T, Nagatsuka H et al. Expression and characterization of PGD2 receptors in chronic rhinosinusitis: modulation of DP and CRTH2 by PGD2. Int Arch Allergy Immunol 2009;148:127136.
  • 31
    Pérez-Novo CA, Holtappels G, Vinall SL, Xue L, Zhang N, Bachert C et al. CRTH2 mediates the activation of human Th2 cells in response to PGD(2) released from IgE/anti-IgE treated nasal polyp tissue. Allergy 2010;65:304310.
  • 32
    Karp CL, Flick LM, Park KW, Softic S, Greer TM, Keledjian R et al. Defective lipoxin-mediated anti-inflammatory activity in the cystic fibrosis airway. Nat Immunol 2004;5:388392.
  • 33
    Bonnans C, Mainprice B, Chanez P, Bousquet J, Urbach V. Lipoxin A4 stimulates 1 a cytosolic Ca2+ 2 increase in human bronchial epithelium. J Biol Chem 2003;278:1087910884.
  • 34
    Kowalski ML, Cieslak M, Perez-Novo CA, Makowska JS, Bachert C. Clinical and immunological determinants of severe/refractory asthma (SRA): association with Staphylococcal superantigen-specific IgE antibodies. Allergy 2011;66:3238.
  • 35
    Szczeklik A, Nizankowska E, Duplaga M. Natural history of aspirin-induced asthma. AIANE Investigators. European Network on Aspirin-Induced Asthma. Eur Respir J 2000;16:432436.
  • 36
    Szczeklik A, Gryglewski RJ, Czerniawska-Mysik G. Relationship of inhibition of prostaglandin biosynthesis by analgesics to asthma attacks in aspirin-sensitive patients. Br Med J 1975;1:6769.
  • 37
    Szczeklik A, Sladek K, Dworski R, Nizankowska E, Soja J, Sheller J et al. Bronchial aspirin challenge causes specific eicosanoid response in aspirin-sensitive asthmatics. Am J Respir Crit Care Med 1996;154:16081614.
  • 38
    Bochenek G, Nagraba K, Nizankowska E, Szczeklik A. A controlled study of 9alpha,11beta-PGF2 (a prostaglandin D2 metabolite) in plasma and urine of patients with bronchial asthma and healthy controls after aspirin challenge. J Allergy Clin Immunol 2003;111:743749.
  • 39
    Daffern PJ, Muilenburg D, Hugli TE, Stevenson DD. Association of urinary leukotriene E4 excretion during aspirin challenges with severity of respiratory responses. J Allergy Clin Immunol 1999;104:559564.
  • 40
    Yamaguchi H, Higashi N, Mita H, Ono E, Komase Y, Nakagawa T et al. Urinary concentrations of 15-epimer of lipoxin A(4) are lower in patients with aspirin-intolerant compared with aspirin-tolerant asthma. Clin Exp Allergy 2011;41:17111718.
  • 41
    Swierczynska M, Nizankowska-Mogilnicka E, Zarychta J, Gielicz A, Szczeklik A. Nasal versus bronchial and nasal response to oral aspirin challenge: Clinical and biochemical differences between patients with aspirin-induced asthma/rhinitis. J Allergy Clin Immunol 2003;112:9951001.
  • 42
    Kowalski ML, Sliwinska-Kowalska M, Igarashi Y, White MV, Wojciechowska B, Brayton P et al. Nasal secretions in response to acetylsalicylic acid. J Allergy Clin Immunol 1993;91:580598.
  • 43
    Cowburn AS, Sladek K, Soja J, Adamek L, Nizankowska E, Szczeklik A et al. Overexpression of leukotriene C4 synthase in bronchial biopsies from patients with aspirin-intolerant asthma. J Clin Invest 1998;101:834846.
  • 44
    Schmid M, Gode U, Schafer D, Wigand ME. Arachidonic acid metabolism in nasal tissue and peripheral blood cells in aspirin intolerant asthmatics. Acta Otolaryngol 1999;119:277280.
  • 45
    Picado C, Bioque G, Roca-Ferrer J, Pujols L, Mullol J, Benitez P et al. Nuclear factor-kappaB activity is down regulated in nasal polyps from aspirin-sensitive asthmatics. Allergy 2003;58:122126.
  • 46
    Kowalski ML, Pawliczak R, Wozniak J, Siuda K, Poniatowska M, Iwaszkiewicz J et al. Differential metabolism of arachidonic acid in nasal polyp epithelial cells cultured from aspirin-sensitive and aspirin-tolerant patients. Am J Respir Crit Care Med 2000;161:391398.
  • 47
    Corrigan CJ, Napoli RL, Meng Q, Fang C, Wu H, Tochiki K et al. Reduced expression of the prostaglandin E(2) receptor E-prostanoid 2 on bronchial mucosal leukocytes in patients with aspirin-sensitive asthma. J Allergy Clin Immunol 2012;129:16361646.
  • 48
    Pierzchalska M, Szabo Z, Sanak M, Soja J, Szczeklik A. Deficient prostaglandin E2 production by bronchial fibroblasts of asthmatic patients, with special reference to aspirin-induced asthma. J Allergy Clin Immunol 2003;111:10411048.
  • 49
    Pierzchalska M, Soja J, Wos M, Szabo Z, Nizankowska-Mogielnicka E, Sanak M et al. Deficiency of cyclooxygenases transcripts in cultured primary bronchial epithelial cells of aspirin-sensitive asthmatics. J Physiol Pharmacol 2007;58:207218.
  • 50
    Mastalerz L, Sanak M, Gawlewicz-Mroczka A, Gielicz A, Cmiel A, Szczeklik A et al. Prostaglandin E2 systemic production in patients with asthma with and without aspirin hypersensitivity. Thorax 2008;63:2734.
  • 51
    Sanak M, Levy BD, Clish CB, Chiang N, Gronert K, Mastalerz L et al. Aspirin-tolerant asthmatics generate more lipoxins than aspirin-intolerant asthmatics. Eur Respir J 2000;16:4449.
  • 52
    Kupczyk M, Antczak A, Kuprys-Lipinska I, Kuna P. Lipoxin A4 generation is decreased in aspirin-sensitive patients in lysine-aspirin nasal challenge in vivo model. Allergy 2009;64:17461752.
  • 53
    Mastalerz L, Sanak M, Kumik J, Gawlewicz-Mroczka A, Celejewska-Wojcik N, Cmiel A et al. Exhaled eicosanoids following bronchial aspirin challenge in asthma patients with and without aspirin hypersensitivity: the pilot study. J Allergy (Cairo) 2012;2012:696792.
  • 54
    Jedrzejczak-Czechowicz M, Lewandowska-Polak A, Bienkiewicz B, Kowalski ML. Involvement of 15-lipoxygenase and prostaglandin EP receptors in aspirin-triggered 15-hydroxyeicosatetraenoic acid generation in aspirin-sensitive asthmatics. Clin Exp Allergy 2008;38:11081116.
  • 55
    Kowalski ML, Borowiec M, Kurowski M, Pawliczak R. Alternative splicing of cyclooxygenase-1 gene: altered expression in leucocytes from patients with bronchial asthma and association with aspirin-induced 15-HETE release. Allergy 2007;62:628634.
  • 56
    Choi YW, Herman A, DiGiusto D, Wade T, Marrack P, Kappler J. Residues of the variable region of the T cell-receptor beta-chain that interact with S. aureus toxin superantigens. Nature 1990;346:471473.
  • 57
    Langley R, Patel D, Jackson N, Clow F, Fraser JD. Staphylococcal superantigen 1 super-domains in immune evasion. Crit Rev Immunol 2010;30:149165.
  • 58
    Ba L, Zhang N, Meng J, Zhang J, Lin P, Zhou P et al. The association between bacterial colonization and inflammatory pattern in Chinese chronic rhinosinusitis patients with nasal polyps. Allergy 2011;66:12961303.
  • 59
    Foreman A, Holtappels G, Psaltis AJ, Jervis-Bardy J, Field J, Wormald PJ et al. Adaptive immune responses in Staphylococcus aureus biofilm-associated chronic rhinosinusitis. Allergy 2011;66:14491456.
  • 60
    Zhang N, Holtappels G, Gevaert P, Patou J, Dhaliwal B, Gould H et al. Mucosal tissue polyclonal IgE is functional in response to allergen and SEB. Allergy 2011;66:141148.
  • 61
    Krysko O, Holtappels G, Zhang N, Kubica M, Deswarte K, Derycke L et al. Alternatively activated macrophages and impaired phagocytosis of S. aureus in chronic rhinosinusitis. Allergy 2011;66:396403.
  • 62
    Gevaert P, Holtappels G, Johansson SG, Cuvelier C, Cauwenberge P, Bachert C et al. Organization of secondary lymphoid tissue and local IgE formation to Staphylococcus aureus enterotoxins in nasal polyp tissue. Allergy 2005;60:7179.
  • 63
    Okano M, Takishita T, Yamamoto T, Hattori H, Yamashita Y, Nishioka S et al. Presence and characterization of sensitization to staphylococcal enterotoxins in patients with allergic rhinitis. Am J Rhinol 2001;15:417421.
  • 64
    Corriveau MN, Zhang N, Holtappels G, Van Roy N, Bachert C. Detection of Staphylococcus aureus in nasal tissue with peptide nucleic acid-fluorescence in situ hybridization. Am J Rhinol Allergy 2009;23:461465.
  • 65
    Patou J, Gevaert P, Van Zele T, Holtappels G, Van Cauwenberge P, Bachert C et al. Staphylococcus aureus enterotoxin B, protein A, and lipoteichoic acid stimulations in nasal polyps. J Allergy Clin Immunol 2008;121:110115.
  • 66
    Huvenne W, Callebaut I, Reekmans K, Hens G, Bobic S, Jorissen M et al. Staphylococcus aureus enterotoxin B augments granulocyte migration and survival via airway epithelial cell activation. Allergy 2010;65:10131020.
  • 67
    Van Zele T, Gevaert P, Watelet JB, Claeys G, Holtappels G, Claeys C et al. Staphylococcus aureus colonization and IgE antibody formation to enterotoxins is increased in nasal polyposis. J Allergy Clin Immunol 2004;114:981983.
  • 68
    Pérez-Novo CA, Kowalski ML, Kuna P, Ptasinska A, Holtappels G, Van Cauwenberge P et al. Aspirin sensitivity and IgE antibodies to Staphylococcus aureus enterotoxins in nasal polyposis: studies on the relationship. Int Arch Allergy Immunol 2004;133:255260.
  • 69
    Lee JY, Kim HM, Ye YM, Bahn JW, Suh CH, Nahm D et al. Role of staphylococcal superantigen-specific IgE antibodies in aspirin-intolerant asthma. Allergy Asthma Proc 2006;27:341346.
  • 70
    Pérez Novo CA, Jedrzejczak-Czechowicz M, Lewandowska-Polak A, Claeys C, Holtappels G, Van Cauwenberge P et al. T cell inflammatory response, Foxp3 and TNFRS18-L regulation of peripheral blood mononuclear cells from patients with nasal polyps-asthma after staphylococcal superantigen stimulation. Clin Exp Allergy 2010;40:13231332.
  • 71
    Mehindate K, Al-Daccak R, Dayer JM, Kennedy BP, Kris C, Borgeat P et al. Superantigen-induced collagenase gene expression in human IFN-gamma-treated fibroblast-like synoviocytes involves prostaglandin E2. Evidence for a role of cyclooxygenase-2 and cytosolic phospholipase A2. J Immunol 1995;155:35703577.
  • 72
    Yamamura Y, Gupta R, Morita Y, He X, Pai R, Endres J et al. Effector function of resting T cells: activation of synovial fibroblasts. J Immunol 2001;166:22702275.
  • 73
    Pérez-Novo CA, Waeytens A, Claeys C, Cauwenberge PV, Bachert C. Staphylococcus aureus enterotoxin B regulates prostaglandin E2 synthesis, growth, and migration in nasal tissue fibroblasts. J Infect Dis 2008;197:10361043.
  • 74
    Okano M, Fujiwara T, Haruna T, Kariya S, Makihara S, Higaki T et al. Prostaglandin E(2) suppresses staphylococcal enterotoxin-induced eosinophilia-associated cellular responses dominantly through an E prostanoid 2-mediated pathway in nasal polyps. J Allergy Clin Immunol 2009;123:868874.
  • 75
    Wehner J, Neuber K. Staphylococcus aureus enterotoxins induce histamine and leukotriene release in patients with atopic eczema. Br J Dermatol 2001;145:302305.